Boston Scientific BSX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.2%+0.5pp | 69%+0.4pp | 68.6%-0.4pp | 68.3%-0.7pp | 68.7%-0.6pp | |
| Operating margin | 18.4%+2.2pp | 18%+2.5pp | 17.9%+2.1pp | 17%+0.8pp | 16.2%-0.5pp | |
| Net margin | 17.3%+5.7pp | 14.4%+3.4pp | 14.4%+3.2pp | 13.5%+1.5pp | 11.5%-0.5pp | |
| Returns | ||||||
| Return on equity | 14.8%+5.2pp | 12.6%+3.6pp | 12.6%+3.6pp | 11.7%+2.2pp | 9.6%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.9×+0.4× | 1.6×+0.5× | 1.5×0.0× | 1.4×-0.2× | 1.5×-0.2× | |
| Per Share | ||||||
| Book value per share | $17.30+16.3% | $16.21+10.7% | $15.64+12.4% | $15.01+9.4% | $14.88+10.6% | |
| Valuation | ||||||
| Market capitalization | $93.26B-37.5% | $141.35B+7.4% | $144.66B+17.2% | $154.04B+36.1% | $149.21B+48.2% | |
| Price / earnings | 26.2×-47.5× | 48.9×-22.5× | 52×-17.1× | 61.7×-0.4× | 73.7×+16.9× | |
| Price / sales | 4.5×-4.0× | 7×-0.8× | 7.5×-0.3× | 8.3×+0.9× | 8.5×+1.7× | |
| Price / book | 3.6×-3.1× | 5.8×-0.2× | 6.2×+0.2× | 6.9×+1.3× | 6.7×+1.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's profit margins?
- Boston Scientific (BSX) runs a 69.2% gross margin and a 18.4% operating margin, with a 17.3% net margin.
- Where do Boston Scientific's ratios come from?
- Every ratio is computed from Boston Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
